Public Health Implications of Sickle Cell Trait
Althea M. Grant(Centers for Disease Control and Prevention), Hani K. Atrash(Unknown), Mary Hulihan(Jacksonville College), Lanetta Jordan(University of Miami), Michele A. Lloyd-Puryear(National Institutes of Health), Christopher S. Parker(University College London), Jonathan C. Goldsmith(National Heart Lung and Blood Institute), Melissa Creary(University of Michigan)
Cited by 51
Related Papers
Management of Sickle Cell Disease
|JAMA|2014|1.6k
National Estimates of Marijuana Use and Related Indicators — National Survey on Drug Use and Health, United States, 2002–2014
|MMWR Surveillance Summaries|2016|465
ATPase and Multidrug Transport Activities of the Overexpressed Yeast ABC Protein Yor1p
|Journal of Biological Chemistry|1998|390
Genomic investigation of α‐synuclein multiplication and parkinsonism
|Annals of Neurology|2008|340
Management of Sickle Cell Disease Summary of the 2014 Evidence-Based Report by Expert Panel Members
|Survey of Anesthesiology|2015|270